Stockscreener 앱 받기
73.00
3.27%
2.31
시간 외 거래:
73.00
전일 마감가:
$70.69
열려 있는:
$70.14
하루 거래량:
874.86K
Relative Volume:
1.25
시가총액:
$2.14B
수익:
$267.23M
순이익/손실:
$-83.50M
주가수익비율:
-23.47
EPS:
-3.11
순현금흐름:
$-59.99M
1주 성능:
-5.01%
1개월 성능:
-19.50%
6개월 성능:
-43.68%
1년 성능:
-25.08%
1일 변동 폭
$69.10
$73.53
1주일 범위
$69.10
$80.00
52주 변동 폭
$55.17
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
명칭
Genedx Holdings Corp
전화
888-729-1206
주소
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
73.00 | 2.07B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-09 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | 개시 | Canaccord Genuity | Buy |
| 2025-07-09 | 개시 | Piper Sandler | Overweight |
| 2025-05-15 | 개시 | Guggenheim | Buy |
| 2025-05-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-10 | 개시 | Craig Hallum | Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
모두보기
Genedx Holdings Corp 주식(WGS)의 최신 뉴스
Jefferies reiterates GeneDx stock rating citing data advantage - Investing.com UK
GeneDx Holdings Corp. (WGS) Q4 earnings and revenues beat estimates - MSN
GeneDx Holdings Corp (WGS) Stock Price Down 4.09% on Mar 18 - GuruFocus
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL.com
GeneDx Holdings Corp. Q4 2025 earnings preview - MSN
Oracle Investment Management Inc. Sells 132,500 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Insider Selling: GeneDx (NASDAQ:WGS) CEO Sells 17,179 Shares of Stock - MarketBeat
Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells 5,706 Shares of Stock - MarketBeat
GeneDx CEO Stueland sells $1.32 million in WGS stock By Investing.com - Investing.com India
GeneDx CEO Stueland sells $1.32 million in WGS stock - Investing.com
GeneDx CFO Feeley sells $438k in shares after option exercise - Investing.com
GeneDx Holdings Corp. Experiences Revision in Stock Evaluation Amid Market Fluctuations - Markets Mojo
GeneDx (WGS) CEO exercises RSUs, sells 17,179 shares to cover taxes - Stock Titan
GeneDx (WGS) CFO sells shares to cover RSU tax obligations - Stock Titan
Aug Update: What are the risks of holding GeneDx Holdings CorpWeekly Profit Summary & Community Trade Idea Sharing Platform - baoquankhu1.vn
Aug Ideas: What are the risks of holding GeneDx Holdings CorpLong Setup & AI Forecasted Entry and Exit Points - baoquankhu1.vn
GeneDx Holdings Corp - Analytics Insight
GeneDx Holdings Corp. $WGS Stake Lessened by Fred Alger Management LLC - MarketBeat
Farallon Capital Management LLC Sells 321,677 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Casdin Capital LLC Has $323.99 Million Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Portolan Capital Management LLC Has $4.75 Million Stock Holdings in GeneDx Holdings Corp. $WGS - MarketBeat
Genedx Earnings Call Signals Strong Genomics Growth - TipRanks
New Highs: What makes GeneDx Holdings Corp stock attractive today2026 Price Targets & Verified Stock Trade Ideas - baoquankhu1.vn
Quantitative Investment Management Buys Stake in GeneDx - National Today
Quantitative Investment Management LLC Buys New Position in GeneDx Holdings Corp. $WGS - MarketBeat
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat - MSN
100,284 Shares in GeneDx Holdings Corp. $WGS Bought by Capital International Investors - MarketBeat
Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? - NAI500
Aug Drivers: Does GeneDx Holdings Corp Equity Warrant stock benefit from AI growth2026 Setups & Technical Pattern Alert System - baoquankhu1.vn
GeneDx Holdings Corp. (WGS) latest stock news and headlines - Yahoo Finance Singapore
GeneDx stock falls as Natera launches competing rare disease test - Investing.com India
GeneDx stock falls as Natera launches competing rare disease test By Investing.com - Investing.com Australia
Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note? - Benzinga
Discipline and Rules-Based Execution in WGS Response - Stock Traders Daily
GeneDx at Barclays Conference: Expanding Genetic Testing Horizons - Investing.com South Africa
GeneDx at Barclays Conference: Expanding Genetic Testing Horizons By Investing.com - Investing.com India
AI Stocks: What is the Moat Score of GeneDx Holdings Corp2026 Rallies & Reliable Entry Point Trade Alerts - baoquankhu1.vn
$80,000 per child: gene tests shift kids from ER to planned care - Stock Titan
GeneDx Holdings (WGS) CFO exercises RSUs and sells shares to cover taxes - Stock Titan
WGSWW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
GeneDx (WGS) CEO exercises RSUs, sells shares only to cover taxes - Stock Titan
Why Is Zevra Therapeutics Stock Trading Higher Today? - Bitget
GeneDx outlines $540M–$555M 2026 revenue target as company accelerates market expansion with new sales force - MSN
GeneDx (NASDAQ:WGS) Trading Down 5.6%Time to Sell? - MarketBeat
Is GeneDx Holdings (WGS) Pricing In Its Sharp 27% Weekly Share Price Move? - Yahoo Finance
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
GeneDx Holdings Corp. to Launch Genetic Testing Program with Zevra Therapeutics, Inc. to Support Patients with Suspected Niemann-Pick Disease Type C - marketscreener.com
Eligible Niemann-Pick C patients get faster genetic tests at no charge - Stock Titan
A Look At GeneDx Holdings (WGS) Valuation After Strong Earnings And Genomics AI Developments - Yahoo Finance
Aug Drivers: What are the risks of holding GeneDx Holdings Corp2026 EndofYear Setup & Short-Term Trading Alerts - baoquankhu1.vn
GeneDx CFO Feeley sells $486k in shares - Investing.com Nigeria
Genedx Holdings Corp (WGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Genedx Holdings Corp 주식 (WGS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Mar 16 '26 |
Option Exercise |
0.00 |
18,750 |
0 |
75,626 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Mar 16 '26 |
Sale |
76.80 |
17,179 |
1,319,291 |
58,447 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 16 '26 |
Option Exercise |
0.00 |
7,197 |
0 |
32,854 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 15 '26 |
Option Exercise |
0.00 |
3,815 |
0 |
25,657 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 16 '26 |
Sale |
76.80 |
5,706 |
438,203 |
27,148 |
| Meister Keith A. | Director |
Mar 05 '26 |
Buy |
81.19 |
140,026 |
11,369,152 |
3,228,150 |
| Meister Keith A. | Director |
Mar 03 '26 |
Buy |
70.89 |
29,495 |
2,090,937 |
3,088,124 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 04 '26 |
Sale |
78.61 |
6,187 |
486,370 |
18,674 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Mar 04 '26 |
Sale |
78.61 |
25,459 |
2,001,371 |
38,683 |
| Dechairo Bryan | Chief Operating Officer |
Feb 04 '26 |
Sale |
85.70 |
5,961 |
510,874 |
0 |
0.55%
2.50%
자본화:
|
볼륨(24시간):